RNA, U6 small nuclear 992, pseudogene (RNU6-992P)

RNA, U6 small nuclear 992, pseudogene (RNU6-992P) is a **pseudogene** corresponding to the U6 small nuclear RNA (snRNA) gene family[1]. U6 snRNA is a crucial non-coding RNA component of the spliceosome, the large ribonucleoprotein complex that catalyzes pre-mRNA splicing in eukaryotes[3][5]. However, unlike functional U6 snRNA genes, RNU6-992P has acquired sequence changes that render it non-functional; it does not produce a functional RNA or protein product and does not participate directly in splicing or other canonical cellular processes[1]. Pseudogenes such as RNU6-992P are typically the result of gene duplication or retrotransposition events, and are characterized by loss of coding (or functional RNA) potential due to accumulated mutations or loss of regulatory elements[4]. In rare cases, some pseudogenes can acquire new functions (e.g., acting as competing endogenous RNAs or generating siRNAs), but there is **no evidence indicating that RNU6-992P has any such biological or disease-related function**[1][4]. RNU6-992P should not be considered a therapeutic target, receptor, enzyme, transporter, or clinically actionable molecular entity. Instead, it serves as a genomic remnant without direct relevance to drug targeting or biomarker development. If your interest is the functional U6 small nuclear RNA and its role in splicing, you should refer to **RNA, U6 small nuclear 1** (and similar functional U6 genes)[3][5]. Key points: - RNU6-992P is a **pseudogene** of U6 snRNA, not a functional RNA or protein[1]. - Not a therapeutic target, not associated with drugs, and not a recognized biomarker[1][4]. - Should not be used in target lists for pharmacological or clinical development. - Possible confusion may arise since functional U6 snRNA genes play a key role in the spliceosome, but pseudogenes like RNU6-992P do not[1][3].

Other names

RNU6-992PRNA, U6 Small Nuclear 992, Pseudogene